Comparative Studies of Effects of Vapor- and Liquid-Phase As2O3 on Catalytic Behaviors of V2O5–WO3/TiO2 Catalysts for NH3-SCR
Sign Up to like & getrecommendations! Published in 2020 at "ACS Omega"
DOI: 10.1021/acsomega.0c01734
Abstract: The role of vapor- and liquid-phase As2O3 in deactivating commercial V2O5–WO3/TiO2 catalyst during the NH3-selective catalytic reduction (SCR) process was explored and compared. As2O3 was loaded via vapor deposition (As(vap)) and the wet impregnation (As(imp))… read more here.
Keywords: v2o5 wo3; vapor liquid; liquid phase; as2o3 ... See more keywords
MDM2-Mediated Inhibitory Effect of Arsenic Trioxide on Small Cell Lung Cancer Cell Line by Degrading Mutant p53.
Sign Up to like & getrecommendations! Published in 2023 at "Anti-cancer agents in medicinal chemistry"
DOI: 10.2174/1871520623666230530095435
Abstract: INTRODUCTION Small cell lung cancer (SCLC) is featured by a high TP53 mutant rate. Our previous research found that arsenic trioxide (As2O3) could significantly inhibit the growth and metastasis of SCLC. Studies have shown that… read more here.
Keywords: cell; effect; mutant p53; as2o3 ... See more keywords
The Evaluation of the Ameliorative Effect of Montelukast Against Arsenic Trioxide-Induced Cardiotoxicity in Rats
Sign Up to like & getrecommendations! Published in 2017 at "Jundishapur Journal of Natural Pharmaceutical Products"
DOI: 10.5812/jjnpp.65046
Abstract: Background: Arsenic trioxide (As2O3) is used for treating patients with acute promyelocytic leukemia (APL). The extensive application of this drug has been limited due to its severe cardiotoxicity. Montelukast is a selective leukotriene receptor antagonist… read more here.
Keywords: induced cardiotoxicity; arsenic trioxide; as2o3; cardiotoxicity ... See more keywords